相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H Binding
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
Sonia Davila et al.
NATURE GENETICS (2010)
The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes
Yogitha N. Srikhanta et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Genome Sequencing Reveals Widespread Virulence Gene Exchange among Human Neisseria Species
Pradeep Reddy Marri et al.
PLOS ONE (2010)
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
Davide Serruto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
Rolando Pajon et al.
VACCINE (2010)
Sequence conservation of pilus subunits in Neisseria meningitidis
Ana Cehovin et al.
VACCINE (2010)
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
Marzia M. Giuliani et al.
VACCINE (2010)
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
Wendell D. Zollinger et al.
VACCINE (2010)
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Han-Qing Jiang et al.
VACCINE (2010)
The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection
John E. Heckels et al.
GENOME MEDICINE (2010)
The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
Lisa A. Lewis et al.
PLOS PATHOGENS (2010)
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles
Andrew R. Gorringe et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
V. Weynants et al.
INFECTION AND IMMUNITY (2009)
Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates
Jeannette N. Williams et al.
INFECTION AND IMMUNITY (2009)
Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years
Yvonne Galloway et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2009)
Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
Alessandro Mascioni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis
Francesca Cantini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
Jay Lucidarme et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis
Ellen Murphy et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins
Ivano de Filippis
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Expression of the meningococcal adhesin NadA is controlled by a transcriptional regulator of the MarR family
Stephanie Schielke et al.
MOLECULAR MICROBIOLOGY (2009)
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Muriel C. Schneider et al.
NATURE (2009)
The modular architecture of meningococcal factor H-binding protein
Peter T. Beernink et al.
MICROBIOLOGY-SGM (2009)
Meningococcal carriage and disease-Population biology and evolution
Dominique A. Caugant et al.
VACCINE (2009)
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
Stefania Bambini et al.
VACCINE (2009)
Genome flexibility in Neisseria meningitidis
Christoph Schoen et al.
VACCINE (2009)
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
Susanne Jacobsson et al.
VACCINE (2009)
A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
Matteo M. E. Metruccio et al.
PLOS PATHOGENS (2009)
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B
J. S. Plested et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease
Dominique A. Caugant
INFECTION GENETICS AND EVOLUTION (2008)
Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis
Caroline O. Buckee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis
Christoph Schoen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis
Vincent E. Weynants et al.
INFECTION AND IMMUNITY (2007)
A prospective study of the effectiveness of the New Zealand meningococcal B vaccine
Colleen Kelly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The analysis of Neisseria meningitidis proteomes:: Reference maps and their applications
Giulia Bernardini et al.
PROTEOMICS (2007)
Functional and specific antibody responses in adult volunteers in new Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines
E. Wedege et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
David S. Stephens et al.
LANCET (2007)
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine
Peter T. Beernink et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months
Sharon Wong et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
Germie P. J. M. van den Dobbelsteen et al.
VACCINE (2007)
New functional identity for the DNA uptake sequence in transformation and its presence in transcriptional terminators
O. Herman Ambur et al.
JOURNAL OF BACTERIOLOGY (2007)
Meningococcal meningitis:: Unprecedented incidence of serogroup X-related cases in 2006 in Niger
Pascal Boisier et al.
CLINICAL INFECTIOUS DISEASES (2007)
Imaging of Disease Dynamics during Meningococcal Sepsis
Hong Sjolinder et al.
PLOS ONE (2007)
Affinity-puritied human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis
Michele M. Estabrook et al.
INFECTION AND IMMUNITY (2007)
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
Scott A. Halperin et al.
VACCINE (2007)
Phase variable type III restriction-modification systems of host-adapted bacterial pathogens
Kate L. Fox et al.
MOLECULAR MICROBIOLOGY (2007)
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Caroline L. Trotter et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Molecular typing of meningococci: recommendations for target choice and nomenclature
Keith A. Jolley et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach
Marirosa Mora et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid genetic grouping of factor H-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine
Berit Feiring et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
The majority of genes in the pathogenic Neisseria species are present in non-pathogenic Neisseria lactamica, including those designated as 'virulence genes'
Lori A. S. Snyder et al.
BMC GENOMICS (2006)
Post-genomic vaccine development
Davide Serruto et al.
FEBS LETTERS (2006)
Antigenic shift and increased incidence of meningococcal disease
LH Harrison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic
KH Dyet et al.
EPIDEMIOLOGY AND INFECTION (2006)
The impact of homologous recombination on the generation of diversity in bacteria
WP Hanage et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis
F Cantini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cross-linking analysis of antigenic outer membrane protein complexes of Neisseria meningitidis
S Sánchez et al.
RESEARCH IN MICROBIOLOGY (2006)
Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant:: Proteomic and immunological comparison with detergent-derived outer membrane vesicles
G Ferrari et al.
PROTEOMICS (2006)
Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant
G Sardiñas et al.
VACCINE (2006)
Outer membrane vesicles of the VA-MENGOC-BC (R) vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry
Liliam Uli et al.
PROTEOMICS (2006)
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254
C Vipond et al.
PROTEOMICS (2006)
Prospects for vaccine prevention of meningococcal infection
LH Harrison
CLINICAL MICROBIOLOGY REVIEWS (2006)
Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58
G Mignogna et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis
SP Yazdankhah et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Microsatellite instability regulates transcription factor binding and gene expression
P Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic
KH Dyet et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
Neisseria meningitidis:: an overview of the carriage state
SP Yazdankhah et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
NadA diversity and carriage in Neisseria meningitidis
M Comanducci et al.
INFECTION AND IMMUNITY (2004)
Modulation of the mtrCDE-encoded efflux pump gene complex of Neisseria meningitidis due to a Correia element insertion sequence
CE Rouquette-Loughlin et al.
MOLECULAR MICROBIOLOGY (2004)
Distribution of surface protein variants among hyperinvasive meningococci: Implications for vaccine design
R Urwin et al.
INFECTION AND IMMUNITY (2004)
Multi-locus sequence typing: a tool for global epidemiology
R Urwin et al.
TRENDS IN MICROBIOLOGY (2003)
Asymmetrical distribution of Neisseria miniature insertion sequence DNA repeats among pathogenic and nonpathogenic Neisseria strains
E De Gregorio et al.
INFECTION AND IMMUNITY (2003)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transcriptome-based antigen identification for Neisseria meningitidis
S Kurz et al.
VACCINE (2003)
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
JA Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species
A Perrin et al.
INFECTION AND IMMUNITY (2002)
Genome analysis and strain comparison of Correia repeats and Correia repeat-enclosed elements in pathogenic Neisseria
SV Liu et al.
JOURNAL OF BACTERIOLOGY (2002)
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays
R Grifantini et al.
NATURE BIOTECHNOLOGY (2002)
Neisseria lactamica protects against experimental meningococcal infection
KJ Oliver et al.
INFECTION AND IMMUNITY (2002)
NadA, a novel vaccine candidate of Neisseria meningitidis
M Comanducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Immunization with recombinant opc outer membrane protein from Neisseria meningitidis:: Influence of sequence variation and levels of expression on the bactericidal immune response against meningococci
KA Jolley et al.
INFECTION AND IMMUNITY (2001)
Advances in immunology: Complement (First of two parts).
MJ Walport
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Exploring the evolution of diversity in pathogen populations
S Gupta et al.
TRENDS IN MICROBIOLOGY (2001)
Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection
D West et al.
INFECTION AND IMMUNITY (2001)
Multiple mechanisms of phase variation of PorA in Neisseria meningitidis
A van der Ende et al.
INFECTION AND IMMUNITY (2000)
Functional genomics of Neisseria meningitidis pathogenesis
YH Sun et al.
NATURE MEDICINE (2000)
Using DNA microarrays to study host-microbe interactions
CA Cummings et al.
EMERGING INFECTIOUS DISEASES (2000)
Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study
P Kriz et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2000)
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58
NJ Saunders et al.
MOLECULAR MICROBIOLOGY (2000)
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
SL Martin et al.
VACCINE (2000)
Phase variation of the gonococcal siderophore receptor FetA
SDB Carson et al.
MOLECULAR MICROBIOLOGY (2000)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
H Tettelin et al.
SCIENCE (2000)
Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator
AE Deghmane et al.
EMBO JOURNAL (2000)
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
ED de Kleijn et al.
VACCINE (2000)
分享论文
